Follow upcoming and recent public offerings (IPOs) on the Egyptian Exchange — offer price, shares offered, subscription dates, and first-day trading performance. Data is updated automatically from EGX disclosures and shown as descriptive information only, with no investment recommendation.
First SPAC on the EGX — temporary listing 19 May 2026, issued capital EGP 10M across 10M shares (par EGP 1). Shares cannot trade for 3 months from listing, pending completion of the acquisition.
IPO Date
Jun 28, 2026
IPO Date
Jun 28, 2026
IPO Date
Jun 28, 2026
IPO Date
Jun 28, 2026
IPO Date
Jun 11, 2026
Offer Price
2.97 EGP
Total Value
735M EGP
Day 1 Return
+23.2%
Second IPO of 2026. Up to 247.5M shares (~11% of capital) offered at EGP 2.97. Public tranche oversubscribed 31.35x; trading began on the main market on 11 June 2026, up ~23% on day one.
IPO Date
May 14, 2026
Temporary listing 14 May 2026 under the state-owned company IPO programme; public offering to follow within 6 months.
IPO Date
May 14, 2026
Temporary listing approved 14 May 2026 — issued capital EGP 3bn across 30M shares (par EGP 100); public offering to follow within 6 months. Part of the state-owned company IPO programme.
IPO Date
May 14, 2026
Temporary listing 14 May 2026 — issued capital EGP 630M across 63M shares (par EGP 10); public offering within 6 months. Part of the state IPO programme.
IPO Date
May 14, 2026
Temporary listing 14 May 2026 — issued capital EGP 125.77M across 20.96M shares (par EGP 6); public offering within 6 months. Part of the state IPO programme.
IPO Date
May 6, 2026
EGX granted a temporary listing on 6 May 2026 — issued capital EGP 1.99bn across 199.375M shares (par EGP 10), with the public offering to follow within 6 months. Backed by EFG Hermes and The Sovereign Fund of Egypt.
IPO Date
Feb 10, 2026
First IPO of 2026 on the EGX, led by EFG Hermes. Public offering oversubscribed 55x, with the stock surging ~38% on its first trading day.
IPO Date
Dec 1, 2025
Offer Price
15.00 EGP
Total Value
1500M EGP
Egypt Pharma Industries IPO on the Egyptian Exchange
IPO Date
Jul 1, 2024
Offer Price
17.20 EGP
Total Value
10750M EGP
Day 1 Return
+7.6%
ADIB Egypt IPO on the Egyptian Exchange
IPO Date
Jun 1, 2023
Offer Price
16.00 EGP
Total Value
2400M EGP
Eastern Company secondary offering
IPO Date
Oct 30, 2022
Offer Price
7.00 EGP
Total Value
2478M EGP
Day 1 Return
+7.1%
CIRA Education IPO on the Egyptian Exchange
IPO Date
Oct 13, 2021
Offer Price
13.98 EGP
Total Value
6584M EGP
Day 1 Return
+28.8%
Largest EGX IPO — e-finance for Digital & Financial Investments
IPO Date
Jun 6, 2021
Offer Price
5.96 EGP
Total Value
1043M EGP
Day 1 Return
+4.0%
Macro Group Pharmaceuticals IPO on EGX
IPO Date
Dec 14, 2020
Offer Price
5.75 EGP
Total Value
2070M EGP
Day 1 Return
+4.9%
TAQA Arabia IPO on the Egyptian Exchange
IPO Date
Aug 7, 2019
Offer Price
6.46 EGP
Total Value
2326M EGP
Day 1 Return
+23.8%
Fawry IPO — first Egyptian fintech on EGX
IPO Date
Apr 1, 2019
Offer Price
3.50 EGP
Total Value
350M EGP
Day 1 Return
+8.6%
Ramco IPO on the Egyptian Exchange
IPO Date
Mar 1, 2019
Offer Price
14.50 EGP
Total Value
1058M EGP
Edita Food Industries secondary offering
An Initial Public Offering (IPO) is the first sale of a company's shares to the public on the Egyptian Exchange (EGX). It lets investors buy the company's shares for the first time at the set offer price before they start trading on the open market.
The FoudaLens IPO tracker lists upcoming offerings, open subscription windows, and recently listed stocks — with offer price, shares offered, and first-trading date — updated automatically from Egyptian Exchange disclosures.
"Upcoming" means the offering is under approval and subscription has not opened yet. "Subscription" means the order-entry window is currently open. "Listed" means the stock has already started trading on the exchange.
No. FoudaLens is a quantitative-analysis and educational platform. It shows IPO data (offer price, dates, performance) as descriptive information only and does not provide investment recommendations. Any investment decision is your own after your own research.